- Chronicles of EGFR Tyrosine Kinase Inhibitors: Targeting EGFR C797S Containing Triple Mutations
-
Duggirala KB, Lee Y, Lee K
- KMID: 2524143
- Biomol Ther.
- 2022 Jan;30(1):19-27.
- doi: 10.4062/biomolther.2021.047
Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase widely expressed in many cancers such as non-small cell lung cancer (NSCLC), pancreatic cancer, breast cancer, and head and neck... -
- CITED
-
- Close
- SHARE
-
- Close
